financetom
Business
financetom
/
Business
/
bioAffinity Technologies Secures Japanese Patent for Lung Cancer Diagnostic Method
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
bioAffinity Technologies Secures Japanese Patent for Lung Cancer Diagnostic Method
Oct 30, 2024 8:02 AM

10:42 AM EDT, 10/30/2024 (MT Newswires) -- bioAffinity Technologies (BIAF) said Wednesday it received a Japanese patent for its CyPath Lung diagnostic test method, which predicts lung cancer risk.

The patent expands bioAffinity's portfolio to 17 granted patents, the company said.

Shares of bioAffinity rose 2.7% in recent trading.

Price: 1.34, Change: +0.03, Percent Change: +2.69

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pfizer's Core Drugs Offset COVID Revenue Drop, Lifts 2025 Profit Outlook Despite Tariffs
Pfizer's Core Drugs Offset COVID Revenue Drop, Lifts 2025 Profit Outlook Despite Tariffs
Nov 4, 2025
On Tuesday, Pfizer Inc ( PFE ). reported third-quarter 2025 adjusted earnings of 87 cents, compared to $1.06 a year ago, beating the consensus of 63 cents. PFE shares are experiencing downward pressure. Get the inside scoop here Pfizer's ( PFE ) third-quarter sales fell 6% year over year to $16.65 billion, beating the consensus of $16.59 billion. The revenue reflected an...
Novo Nordisk Submits 'Superior' Amended Proposal to Acquire Metsera
Novo Nordisk Submits 'Superior' Amended Proposal to Acquire Metsera
Nov 4, 2025
09:24 AM EST, 11/04/2025 (MT Newswires) -- Metsera ( MTSR ) said Tuesday it has received an amended acquisition proposal from Novo Nordisk ( NVO ) that its board determined constitutes a Superior Company Proposal as defined under its existing merger agreement with Pfizer ( PFE ) . The revised proposal values Metsera ( MTSR ) at up to roughly...
Humanoid Global Commits US$75,000 to Strategic Investment in HowToRobot
Humanoid Global Commits US$75,000 to Strategic Investment in HowToRobot
Nov 4, 2025
09:24 AM EST, 11/04/2025 (MT Newswires) -- Humanoid Global ( RBOHF ) , which jumped 29% on Monday, announced that it has committed US$75,000 to a strategic investment in HOWTOROBOT HOLDING INC. (HowToRobot). The company earlier Tuesday said HowToRobot intends to support the automation and robotics strategy across its portfolio companies. HowToRobot has become a go-to platform for companies seeking...
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up
Nov 4, 2025
Nov 4 (Reuters) - Novo Nordisk and Pfizer ( PFE ) have revised their bids for Metsera ( MTSR ), the obesity drug developer said on Tuesday. Novo's revised offer brings the deal value to about $10 billion, while Pfizer ( PFE ) is now willing to shell out $8.1 billion. The revised bids come as both companies are engaged...
Copyright 2023-2026 - www.financetom.com All Rights Reserved